Hera BioLabs Announces Exclusive Global License With Charles River
March 16, 2022 08:05 ET
|
Hera Biolabs
LEXINGTON, Ky., March 16, 2022 (GLOBE NEWSWIRE) -- Hera BioLabs, an innovative service and technology provider with novel genetic engineering products, has announced a collaboration with Charles...
Poseida Therapeutics to Present Three Abstracts on Novel BCMA-Specific CAR-T Therapy at American Society of Hematology 2016 Annual Meeting
November 03, 2016 09:00 ET
|
Poseida Therapeutics, Inc.
SAN DIEGO, Nov. 03, 2016 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene editing technologies into lifesaving therapeutics, today...